June 2001
Diabetech
Inception
The company begins from a family need: glucose information needed to move at the speed of real life.
Roadmap
A signal stream toward better health systems.
The Diabetech lineage is best understood as a vertical evidence stream. Each stage moved patient data closer to timely action, then carried that operating model into virtual care, regulated clinical development, Operational Telemetry, real-time trial thinking, and PatientStories.ai.
Pedigree
From purpose-built telemetry to patient signal systems.
Green and blue cards represent the built lineage. The amber COVID-19 card is an external stress test. Side-current cards capture important context without distracting from the main sequence.
2001
Diabetech
First patent application
The early intellectual-property work framed remote diabetes telemetry before connected care became market language.
Dec. 19, 2002
Diabetech
Field deployment with actual patients
The system moved from concept into real patient use, establishing the practical operating model for remote diabetes telemetry.
1998–2005
Compaq → Diabetech
iPAQ PDA + GSM expansion jacket
Part of the handheld/mobile-data roadmap that led to the iPhone: pocket computing, cellular data, mobile commerce, and always-connected workflows before smartphones consolidated the category.
2003–2004
Diabetech
GlucoMON-ADMS / GlucoDYNAMIX
Device data became backend workflow, rules-based feedback, reporting, and remote monitoring logic.
Mid-2000s
HealthCordia
Disease-management programs
The model evolved from device telemetry into structured patient engagement, payer/employer programs, and diabetes health-care extender workflows.
Later 2000s
Healthimo
Population-health systems
The operating model broadened toward population-health and international deployment framing.
2009+
Diabetech / McKesson subcontract
Medicaid virtual diabetes program at scale
Diabetech won the Medicaid tele-monitoring business and operated the program as a subcontractor to McKesson, recruiting from a pool of more than 1,500 diagnosed adults with type 2 diabetes.
Commercial lineage
Philips
Virtual Care Management
The lineage moved into commercial virtual-care infrastructure.
2019–2024
Ultragenyx
Crossing into GCP-grade clinical trial operations
The operating model crossed the chasm from digital health into regulated clinical development, remote patient data, disease monitoring programs, and GCP-grade execution.
Live at Ultragenyx
Operational Telemetry
DDC + STP live examples
As reflected in public BeyondXLH program materials, direct data capture and straight-through processing moved from concept into software-driven operations: patient data supported regulated study workflows, and aggregated, de-identified community statistics could be displayed on the web in near real time.
2020+
External stress test
COVID-19 made remote execution necessary
Telehealth workflows, device logistics, remote data capture, and patient feedback loops became mission-critical rather than optional.
Recent
FDA
Real-Time Clinical Trials
The final validation point: the industry and regulators are now moving toward agreed-upon safety and outcome signals visible while trials are still happening.
Current
PatientStories.ai
Patient signal systems
The current expression of the same principle: real-life patient narratives and signals become structured insight.
Market disruption
iPhone + App Store
The iPhone validated the mobile-data direction, but the app era also pushed buyers toward user-click workflows. Diabetech’s telemetry model was different: remove user interaction from the critical path when possible.
Later exploration
DiaTrends
A later restart concept revisited the original telemetry model with a newer wireless token, portal, and AI-oriented signal layer, but remained exploratory.
Adjacent chapter
Sugar Surfing
The medical-education chapter focused less on moving the data and more on helping people understand patterns and act in real life.